首页 | 本学科首页   官方微博 | 高级检索  
     

利钠肽在急性心力衰竭预后评估及指导治疗中的作用
引用本文:李航顺梁兆光. 利钠肽在急性心力衰竭预后评估及指导治疗中的作用[J]. 现代生物医学进展, 2012, 12(26): 5198-5200
作者姓名:李航顺梁兆光
作者单位:哈尔滨医科大学附属第一医院心血管内科 黑龙江哈尔滨150001
摘    要:
利钠肽(BNP与NT-proBNP)是预测急性心衰预后及评估急性心衰治疗效果可靠的指标.日常临床决策加用利钠肽检测提高了急性心衰高危患者的发现率,而这些患者往往需要加强追踪及强化治疗.现就利钠肽在评估急性心衰预后及指导心衰治疗中的价值作如下综述.

关 键 词:急性心衰  利钠肽  预后  治疗最优化

Utility of Natriuretic Peptides Testing in the Evaluation and Managementof Acute Heart Failure
LI Hang-shun,LIANG Zhao-guang. Utility of Natriuretic Peptides Testing in the Evaluation and Managementof Acute Heart Failure[J]. Progress in Modern Biomedicine, 2012, 12(26): 5198-5200
Authors:LI Hang-shun  LIANG Zhao-guang
Affiliation:△(Department of Cardiology,The First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150001,China)
Abstract:
Natriuretic peptides(B-type natriuretic peptide(BNP) and N-terminal pro-B-type natriuretic peptide(NT-pro-BNP))are reliable tools for establishing prognosis and evaluating the effectiveness of treatment of acutely heart failure.The addition of BNP and NT-proBNP to usual clinical decision making enhances detection of high-risk patients who need aggressive follow-up and adjustment of treatment.we present an overview of the value of natriuretic peptides in the context of acute heart failure prognosis and treatment therapy optimization.
Keywords:Acute heart failure  Natriuretic peptide  Prognosis  Treatment therapy optimization
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号